TAT-HA2 Fusion Peptide - HY-P4108
Nur noch %1 verfügbar
Catalog #
HY-P4108
Ab
231,20 €
Regular Price
289,00 €
TAT-HA2 Fusion Peptide is a peptide-based delivery agent that combines the pH-sensitive HA2 fusion peptide from Influenza and the cell-penetrating peptide TAT from HIV. TAT-HA2 Fusion Peptide is a transactivator of transcription and hemaglutanin for endosomal release. TAT-HA2 Fusion Peptide enhances cellular uptake of macromolecules[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P4108/TAT-HA2-Fusion-Peptide-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | COVID-19-anti-virus |
| CAS | 923954-79-4 |
| Storage | -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen) |
| MWT | 3432.92 |
| Solubility | H2O : 100 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | No Development Reported |
| Target | Influenza Virus |
| Application: | COVID-19-anti-virus |
|---|